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1 Introduction and review of literature  
Human gingival tissues cover the tooth-carrying alveolar bone and its inserting teeth. 
One of its special features is its great regenerative and wound healing ability with little 
if any scarring evidence [118]. The multiple functions of connective tissue fibroblasts 
of the human gingiva, their wide spectrum in responsiveness to different 
growth/differentiation factors as well as in the capacity to form an array of characteristic 
extracellular matrix proteins throughout the healing processes presents their 
heterogeneous nature [81, 180, 182, 200, 204] and proposes the presence of a 
population of stem/progenitor cells, providing this heterogeneous culture of cells. 
Former studies presented isolation techniques of oral cavity’ soft tissue derived 
stem/progenitor cells [62, 138, 149, 219, 223, 245]. Studies showed favourable 
characteristics of gingival stem/progenitor cells, including its immunomodulatory 
properties [256], besides their biocompatibility with scaffolds of alginate hydrogel 
microbeads [151]. Recently, stem/progenitor cells, originating from the free gingival 
margin (G-MSCs) showed significant abilities of generation in-vivo [57]. 
Toll-like receptors (TLRs) are important players connecting innate and acquired 
immune reactions. They are germ line-encoded pattern-recognition receptors (PRRs) 
that identify specific pathogen-associated molecular patterns (PAMPs) and induce 
activation [72, 107]. They can recognize invading microbes and show an association 
in chronic diseases’ pathogenesis, autoimmune disorders and different infections [36]. 
To date, investigations were able to characterize ten functional human TLRs. [129]. 
Depending on their localization in the cells and their specific PAMP ligands, TLRs are 
classified into extracellular and intracellular TLRs. Extracellular TLRs are expressed 
on cell surfaces and mostly identify constituents of the pathogens’ cell membranes 
including lipids and lipoproteins (TLR1, TLR2 and TLR6), lipopolysaccharide (LPS) 
(TLR4), and flagellin (TLR5). The second category of TLRs is formed intracellularly 
and mostly identify double-stranded RNA (TLR3), single-stranded viral RNA (TLR7 and 
TLR8) and unmethylated CpG DNA of viruses and bacteria (TLR9) [100]. 
MSCs from various sources within the body have been shown to express functional 
TLRs in certain patterns, which allow them to become selectively sensitive to 
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pathogenic and microbial compounds. When stimulated by their ligands, TLRs can 
modulate immunosuppressive, proliferative, migratory and differentiation abilities of 
MSCs [31, 129, 224, 231]. Studies have shown differential expressions of TLRs 1, 2, 
3, 4, 5, 6 on human and mural adipose and bone marrow derived MSCs (BM-MSCs), 
human Wharton Jelly MSCs (WJ-MSCs), on human umbilical cord blood MSCs (UCB-
MSCs) and on human MSCs from the dental follicle and the dental pulp [187, 225, 
231]. These investigations showed that the specific pattern of TLRs expression differs 
according to the tissue of origin of the MSCs, which could have an effect on the MSCs’ 
therapeutic potential during treatment procedures utilizing these cells for 
transplantation in inflammatory milieus in-vivo [42]. 
G-MSCs are currently in experimental employment in therapeutic modalities for 
inflammatory conditions as the treatment of periodontitis [57] and colitis [256]. To date, 
no expression profile exists for the TLRs of G-MSCs, although gingiva has been proven 
as a good source and reservoir harbouring MSCs [255] 
 
1.1 The immune system 
Protecting the human body against possible threats of invading pathogens relies upon 
a series of natural mediators that are able to recover the homeostasis and preserve it 
[143]. This biological mechanism of protection consists of cells and molecules 
opposing the microbes discovered by the immune system, initially developed in the 
human embryo. This process begins with hematopoietic stem cells which differentiate 
into the main players of the immune response in our bodies (granulocytes, monocytes, 
and lymphocytes). Through the different functions and activities of these main units of 
immunity the immune response contains two major divisions, the innate and the 
adaptive responses (Fig.1).  
The innate immunity incorporates different barriers of microbiological, chemical and 
physical nature but also provides the components of our immunity responsible for 
immediate action against the invading pathogens. Although this defensive action is 
rapid, it lacks specificity and might cause some damage to normal tissues. On the 
contrary, the adaptive immune response shows a much higher precision in its 
defensive mechanism, but takes several weeks or days to develop. This can be 
Introduction and review of literature 
 
8 
 
explained by the development of an immunological memory by the adaptive immunity, 
which allows specific responses against the pathogens and much less damage to the 
normal tissues than the innate response. 
 
1.1.1 The innate immune system 
The innate immunity refers to semi-specific mechanisms of defence starting 
immediately or within a short time of a pathogen’s appearance in the body [43, 124, 
133]. In this immune response the germline-encoded receptors’ genetic memory 
facilitates the recognition of certain molecular motifs of common microbes [21, 43]. It 
is accountable for primary forms of protection against invading threats. Simple physical 
and chemical barriers such as epithelial layers of cells and mucous secretions lining 
multiple tracts, such as the gastrointestinal tract or the oral mucosa, contribute to this 
first line of defence [26, 35, 84]. In addition, bioactive molecules and soluble proteins 
present in biological fluids of the body as complement proteins or cellular secretions of 
cytokines are able to debilitate a wide range of invading pathogens [26]. Furthermore, 
Source: http://drrajivdesaimd.com/wp-content/uploads/2013/04/innate-
vs.-adaptive.png  
Figure 1: The innate and adaptive branches of the immunity 
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cellular components of the innate response include dendritic cells, macrophages and 
natural killer cells [26, 35, 84]. In order to ensure the restoration of homeostasis and 
clearance of invading microbes the innate response has to fulfil the fundamental 
process of early pathogen recognition. This procedure principally takes place by a 
group of receptors termed the Pattern Recognition Receptors (PRR). These receptors 
have the ability to recognize conserved microbial patterns known as Pathogen-
Associated Molecular Patterns (PAMPs) [121]. The human PRRs include Toll-like 
Receptors (TLRs) recognizing bacteria, fungi and viruses; Nod-like receptors (NLRs) 
detecting bacteria and the retinoic acid inducible gene-I (RIG-I)-like receptors (RLRs) 
that distinguish viruses [37, 114]. Following PAMP-PRR recognition a reaction cascade 
is initiated by cells of the innate immunity generating antimicrobial agents as reactive 
oxygen. In conjunction with that, generated chemokines and cytokines facilitate 
immune cell recruitment favouring the clearance of pathogenic organisms. Moreover, 
the stimulation of PRR leads to the synthesis of acute phase proteins, such as C-
Reactive Protein and complement factors, with antimicrobial functions. The activated 
innate response of the immune system is fundamental for the onset of the adaptive 
response as both branches of the immunity do not operate separately, but rely on their 
interdependent functions [63, 101]. 
 
1.1.2 The adaptive immune system  
Successive to the innate immune response the second arm of immunity commences. 
This adaptive (acquired) response is unlike the innate reaction characterized by being 
highly specific against certain organisms. This is promoted by a special ability of the 
cells of the adaptive arm of immunity to implement a recombination of their antigen 
receptors. This provides these cells with specific receptors for invading pathogens and 
generates the immunological memory of the body, by which pathogens are identified 
distinctively [35]. As this process may require 3 to 5 days the innate immunity has to 
coordinate and fulfil its functions in order to protect the body as the first line of defence 
[143] The adaptive response is composed of a group of specialized cells originating 
during haematopoiesis from lymphoid cell lineage. Among these are CD4+ and CD8+ 
T-cells as well as B-Lymphocytes that are responsible for antibody production [102]. 
The antibodies provide the humoral immunity which play different roles in the defence 
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against pathogenic invasion. As B-Lymphocytes produce large numbers of 
antibodies, pathogens and their products can be identified and cleared. After 
pathogen recognition the antibodies bind to the pathogens, allowing their neutralization 
and preventing the access of pathogenic organisms into the host cells. Other functions 
of antibodies perform an incitement of phagocytic immune cells as macrophages and 
neutrophils as well as natural killer cells. They also form the first step of complement 
cascade activation through antigen-antibody complexes to enable the phagocytosis of 
unrecognized bacteria. This is facilitated through the antibodies’ opsonisation 
mechanism to microbial organisms. On the other hand killing infected cells is operated 
by T cells, as the second cellular component of the acquired immune response [35]. 
 
1.2 Toll-like receptors 
1.2.1  Definition and discovery 
The Toll Receptor family was the earliest group of PRRs to be discovered. In 1985 Toll 
protein was identified and classified as being significant for embryonic growth of the 
fruit fly, Drosophila melanogaster [9]. Another function described in further studies is 
mediating host responses to fungal Aspergillus niger infection and inducing the release 
of antimicrobial proteins [123]. Furthermore, a human toll like homologue was reported 
in 1997 [145]. This protein was termed as the Toll-like receptor (TLR) and showed an 
important role in intercommunication between innate and acquired immunity [144]. 
Toll-like receptors are intracellular and extracellular proteins that distinguish classes of 
different molecules. This enables the innate immune response to utilize these 
receptors for sensing microbial pathogenic invasions [216]. By recognizing specific 
microbial products by the TLRs the early immune reaction can be initiated [115]. 
Among PAMPs stimulating TLRs are, lipoproteins, peptidoglycan, lipopolysaccharide, 
bacterial DNA and double-stranded RNA [115]. As a result of this TLR-PAMP complex, 
expressions of pro-inflammatory and defensive genes are induced. Conjointly 
signalling pathways are started activating NF-kB and MAPK, along with promoting 
cytokine (e.g. IL-6 and IL-10) and co-stimulatory molecule production, leading to the 
commencement of the adaptive immune response [4].  
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1.2.2  Identification of TLRs (1-11) 
The earliest mammalian TLR to be reported was TLR4 [141, 144]. The PRR-PAMP 
identification mapped to TLR4 showed a critical role in recognizing the bacterial 
component LPS [184]. Subsequent studies identified a family of 13 mammalian TLRs, 
[95], with TLRs 1 to 10 functional in human cells [129], while non mammalian species 
have shown a broader TLR spectrum [172]. TLRs display a correspondence to IL-1 
receptor family in their cytoplasmic portion. Due to this resemblance the intracellular 
domains of TLRs are termed Toll/IL-1 receptors (TIRs). On the other hand, 
extracellularly the TLRs show leucine-rich repetitions while IL-1 receptors present 
immunoglobulin-like areas [70, 145]. Regarding the TLR family, most consistent 
studies have been aiming attention to TLRs 1-10 in humans and other mammalian 
species. 
 
1.2.3  TLR activating PAMPs and their signalling pathways  
Studies have displayed various molecular components of pathogenic microbes, 
including combinations of nucleic acids, proteins, lipids and carbohydrates as ligands 
(PAMPs) activating the TLRs. Bacterial lipopolysaccharides, lipoproteins and flagellin, 
besides viral RNA are considered amongst the most important members of these 
PAMPs [90, 93, 115]. By activating TLRs by their specific ligands, intracellular 
signalling pathways are induced, promoting factors as MyD88 and NF-κB. MyD88, a 
molecule structurally related to the IL-1R family, is considered one of the main proteins 
utilized by almost all TLRs to start the signalling pathway, promoting the production of 
the transcription factor NF-κB [3]. This nuclear factor can cause both pro- and anti-
inflammatory responses and increases the expression of various genes, including 
chemokines, cytokines, and adhesion molecules [119]. Through these intracellular 
reactions the innate immune response is finally initiated and a signalling cascade is 
formed to resist the invading pathogen (Fig.2). This critical step is the first protective 
mechanism against the microbes, which later also commences the adaptive immunity 
to fight against the pathogens by specific means [4]. Corresponding to their activating 
PAMPs, TLRs can be classified into different subfamilies. For instance, studies have 
demonstrated the recognition of lipids by (TLRs 1, 2 and 6), nucleic acid by (TLRs 7, 8 
and 9) and various ligands by TLR4 [4, 115]. Regarding their site of cellular expression, 
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TLRs 1, 2, 4, 5, 6 and 11 are expressed on the cell surface, while the rest are 
expressed intracellularly [115]  
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The stimulation of the TLR signalling pathway initiates from the cytoplasmic Toll/IL-1 receptor 
(TIR) domain which associates with a TIR domain-containing adaptor, MyD88. After activation 
with PAMPs, MyD88 recruits IL-1 receptor-associated kinase-4 (IRAK-4) to TLRs by 
communicating the death domains of the two molecules. IRAK-1 is triggered by phosphorylation 
and together with TRAF6 it activates the IKK complex and leading to stimulate of MAP kinases 
(JNK, p38 MAPK) and NF-κB. Tollip and IRAK-M interact with IRAK-1 and negatively regulate the 
TLR-mediated signalling cascades. Other modes of control regarding these pathways include 
TRIF-dependent initiation of TRAF6 signalling by RIP1 besides the negative regulation of TIRAP-
mediated downstream signalling by ST2L, TRIAD3A, and SOCS1. Activation of MyD88- 
independent pathways occurs via TRIF and TRAF3, directing to the recruitment of IKKε/TBK1, 
phosphorylation of IRF3, and production of interferon-β. TIR domain containing adaptors such as 
TIRAP, TRIF, and TRAM regulate TLR-mediated signalling reactions by offering specificity for 
individual TLR signalling pathways.  
Source: http://www.cellsignal.com/pathways/nk-kappab-signaling.jsp 
Figure 2: Explanation of Toll-like receptors’ activation and their signalling 
pathways 
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1.2.4  TLR subfamilies 
1.2.4.1 TLR1, TLR2, TLR6 and TLR10 
TLR2 has displayed a broad spectrum of recognized PAMPs. These involve 
pathogenic lipoproteins, gram-positive bacterial peptidoglycans and lipoteichoic acid, 
mycobacterial lipoarabinomannan, Porphyromonas gingivalis fimbriae and fungal 
zymosan [115, 217]. LPS originating from bacteria as Porphyromonas gingivalis, 
Capnocytophaga ochracea and Bacteroides fragilis is also a TLR2 identified ligand 
[115].  
Two mechanisms have been proposed considering the TLR2 recognition of various 
pathogenic components. In the first one, TLR2 creates heterophilic dimers with other 
members of the TLR family that show structural resemblance to it, as TLR1, TLR6 and 
TLR10. Consequently, TLR1, TLR6 and TLR10 are considered associated in their 
function with TLR2 and able to recognize similar or correlated types of PAMPs as 
triacyl and diacyl lipopeptides [114, 216]. The second model suggests the identification 
of fungal proteins by TLR2. This attribute explains why TLR2 functionally associates 
with dectin-1, a receptor recognizing b-glucan, a fungal cell wall constituent [67]. 
Regarding this functional coordination with various types of related or unrelated 
proteins, TLR2 gains its ability to identify various pathogenic molecules at an early 
stage, activating the immune responses. 
 
1.2.4.2  TLR3 
TLR3 mainly identifies dsRNA that is produced in the replication period of most viruses. 
It has the function of activating NF-κB and type I Interferon production [6]. It has been 
also reported that TLR3 can homodimerize with TLR4 and TLR9 [168, 240]. 
 
1.2.4.3 TLR4 
TLR4 is an important receptor recognizing PAMPs as LPS from several bacterial 
species [115]. This type of LPS shows structural differences from the LPS identified by 
TLR2 in the number of acyl chains, which widens the spectrum of pathogen 
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identification by TLRs [164]. In addition other ligands of endogenous nature including 
heat shock proteins (HSP60 and HSP70) can stimulate TLR4 in higher concentrations 
[68].  
 
1.2.4.4 TLR5 
TLR5 can identify flagellin through a mechanism of physical interaction [68, 115]. 
Expression of TLR5 has been reported on epithelial cells of mucosal surfaces of the 
intestine [73] and the lung [85], as well as on mesenchymal cells of adipose, bone 
marrow and umbilical cord origin [120], which presents the important function of 
detecting microbes at these surfaces.  
 
1.2.4.5 TLR7 and TLR8 
TLR7 and TLR8 both show the ability to recognize similar ligands in certain cases. It 
has been reported that the two are activated by organic molecules as Imidazoquinoline 
[115] and by viral ssRNA [45, 87, 132], while host ssRNA is not identified by them, as 
stated by other studies [216]. This recognition starts by viral internalization and 
replication releasing the viral RNA into endosomes. The interaction between the 
viral ssRNA and TLR7/8 activates the recruitment of the adapter molecule 
MyD88 leading to production of NF-κB and other factors as well as 
proinflammatory cytokines and chemokines [105]. 
 
1.2.4.6 TLR9 
TLR9 has the ability to distinguish bacterial DNA [115]. This contains unmethylated 
CpG generating its immunostimulatory effect in contrast to the vertebrate DNA that 
contains methylated CpG only [142]. By activation of TLR9 through the bacterial CpG 
DNA the production of inflammatory cytokines such as IL-12, IFN-α and TNF-α is 
potentiated [89]. The competence of TLR9 to induce IFN-α production besides its 
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competence identifying unmethylated CpG motifs indicates that it may also be 
important in mechanisms of viral pathogen recognition [113].  
 
1.3 Human Mesenchymal Stem Cells  
1.3.1  Definition and history 
Human mesenchymal stem cells were initially defined in 1970 by Friedenstein et al. 
[64]. They were described as bone marrow isolated, non-hematopoietic and plastic-
adherent cells, which hold the capabilities of multipotent differentiation and self-
renewal in vitro [16, 25, 183]. These undifferentiated cells originate from different 
tissues of the human body [104]  
The multilinenage potential and the ability of self-renewal both define the major 
characteristics of MSCs [60]. Self-renewal is the technique by which stem cells expand 
their number during development. This occurs asymmetrically or symmetrically where 
daughter stem cells have a capacity of development similar to their mother cells that 
become committed progenitor cells [86]. This ability is essential for MSCs to expand 
within the tissues and could therefore be very important in stem cell related therapies 
[86]. 
On the other hand this self-renewal depends on the life span of the cells. In humans 
MSCs are restricted to a maximum of 44 weeks [15] or 55 population doublings [91] in 
culture. In addition cell density during culture also influences “stemness” 
characteristics of the MSCs [202].  
Multipotency, or the multilineage potential of MSCs forms the unique ability of the cells 
for differentiation into cells of the mesodermal lineage like osteocytes, chondrocytes 
and adipocytes (Fig.3). In addition MSCs can also differentiate into cells of other 
embryonic lineages [228]. 
These special characteristics of MSCs as well as their interaction with specific signals 
of the human body show great therapeutic potential and may become basic treatment 
options for severe diseases in the future [176, 237].  
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1.3.2  Identification of mesenchymal stem cells 
The identification of MSC populations and the verification of their “stemness“ have 
been confronting researchers in recent years. Without an ability to recognize MSCs 
amongst mixed cell populations’ cultures of MSCs of higher purity would be very 
effortful to achieve. 
Considering this, numerous studies investigated different characteristics of MSCs 
identification. In 2006 the plastic adherence of MSCs maintained under basic culture 
conditions was defined [48]. In addition, the multilineage differentiation potential of 
MSCs in-vivo or in-vitro after stimulation by specialized media was postulated by a 
number of studies [48, 116, 177].  
Another widely reported method for MSCs’ recognition is the analysis of the expression 
of specific surface markers of the cells by flow cytometry. Markers as CD29, CD44, 
CD71, CD73, CD90, CD105, CD106, CD120, CD124, CD166 and Stro-1 show positive 
Source:http://www.sigmaaldrich.com/life-science/stem-
cellbiology/mesenchymal-stem-cells.htm 
Figure 3: Mesenchymal stem cell multilineage differentiation potential 
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expressions on the cell surface, while markers as CD11, CD14, CD18, CD31, CD34, 
CD40, CD45, CD56, CD80 and CD86 are missing or weakly expressed [25, 48, 174]. 
Colony forming units (CFUs), which are cellular colonies formed by the MSCs after 
isolation, were also reported as a method of MSC recognition by CFU assays [54, 174]. 
 
1.3.3  Adult sources of mesenchymal stem cells 
Risks and morbidity of stem cell based therapies have become one of the most 
discussed topics in recent years. This led to wide investigations regarding the 
tumorgenicity of embryonic stem cells [13, 19, 214]. Concurrently, ethical discussions 
about the application of these cells have raised a lot of controversies throughout the 
society, leading a large number of researchers to explore possible sources for adult 
(somatic) stem cells. Despite the fact, that bone marrow has been settled to become 
the primary source of adult mesenchymal stem cells [29, 156], various efforts are being 
done to establish new sources that could provide large numbers of MSCs with less 
donor site morbidity (Fig.4). Among these sources, umbilical cord blood (UCB) [178, 
257], placental tissue [59, 258], wharton jelly [8] and adipose tissue [12, 247] have 
been reported to be possible niches of MSCs. Furthermore, MSCs could be isolated 
from tissues related to the dental field as alveolar bone proper [56], gingiva [54, 103], 
periodontal ligament [80], dental pulp [209] and dental follicle [238]. In spite of the 
phenotypic similarity of MSCs derived from various sources, discrepancies in activities 
and functions of these cells have been observed, underlining the individuality of MSCs 
from every source [186, 197] 
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1.3.4 Gingival mesenchymal stem cells (G-MSCs) 
Gingival tissues have gained the interest of different researchers as a unique reservoir 
for MSCs [103, 248, 255]. While skin, oral mucosa and gingiva show a number of 
analogies in their functions and histological appearance [212], specifically the gingiva 
has displayed particular biological properties suggesting its unique distinction 
compared to other oral mucosal tissues [218]. For instance gingival tissues are 
continuously under influence of factors like oral bacteria, friction or food rests. 
Furthermore, inflammatory responses, drug induced overgrowth and gingival fibrosis 
Source: http://learn.genetics.utah.edu/content/stemcells/quickref 
Figure 4: Possible locations of adult stem cells in the human 
body 
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also differ gingival tissues from other oral mucosa [69, 154]. Among the studies 
presenting gingival tissues as MSC-harbouring reservoirs, some results proposed the 
presence of specific markers related to pluripotent cell characteristics, as Stro-1, 
SSEA-4 and Oct-4 in cells originating from the gingiva [54, 218, 254], in addition to the 
positive staining of p75, a marker normally present in neural stem cells [138]. Besides 
the ability of G-MSCs for self-renewal and multipotent differentiation [218, 222, 239], 
human G-MSCs express CD29, CD44, CD73, and CD90 (> 80%) and CD105, CD146 
and Stro-1, while they show no expression of CD34 and CD45 [255]. This surface 
expression profile of G-MSCs confirms their “stemness” concomitant to the minimal 
criteria for human MSCs as it was proposed in 2006 [48]. 
 
1.3.5  Immunobiology of MSCs  
1.3.5.1 MSCs mediated immunomodulation 
Among the properties of MSCs demonstrated by recent studies, the ability to modulate 
immune responses and inflammatory reactions within the body has been underlined 
[134]. This interaction between MSCs and immunological factors displays an important 
role played by these cells in repairing damaged tissues or protecting them during 
inflammation [206]. 
Tissue injury promotes the activation of inflammatory cells, including CD4+ T cells and 
CD8+ T cells besides the macrophages and neutrophils, releasing specific mediators, 
as IL-1β and TNF-α [134]. These inflammatory changes lead to an organization and 
differentiation of MSCs to repair the damaged tissue. By entering an inflammatory 
milieu released cytokines as IL-1, TNF-α and IFN-γ, in addition to the tissue hypoxia 
activate MSCs to produce growth factors like epidermal growth factor (EGF), fibroblast 
growth factor (FGF), platelet-derived growth factor (PDGF) and vascular endothelial 
growth factor (VEGF). These factors in turn play an effective role in regeneration and 
repair of affected tissues [97, 135, 207]. Even in cases like myocardial infarction some 
studies reported a possible recovery by factors released by MSCs [221]. Moreover, 
MSCs produce a number of molecules as stem cell factor (SCF), macrophage colony-
stimulating factor (M-CSF), and Ang-1, that promote the repair process intrinsically 
[158, 207, 232].  
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Supplementary to the described tissue repairing ability, immunomdulatory functions of 
the MSCs were further demonstrated and explained [134]. Recently, the 
immunosuppressive ability of MSCs has been observed in combination with a milieu 
containing IFN-γ and proinflammatory cytokines as TNF-α, IL1α or IL1β [134]. Such 
inflammatory environment could lead to higher expressions of adhesion molecules and 
chemokines, bringing the immune cells in close vicinity to the MSCs and augmenting 
their potency of immunosuppression [191, 192]. Nevertheless, other evidences 
concerning MSCs mediated immunomodulation confirm the ability of MSCs to elevate 
the immune responses in media of low inflammatory levels [126]. This indicates the 
flexibility of MSCs mediated immunomodulation, depending on the amount of 
inflammation affecting the cells. 
 
1.3.5.2 MSCs and TLRs 
One of the most important factors directing immunomodulatory functions of MCSs into 
pro- or anti-inflammatory responses are TLRs. In the light of these results TLRs 
expression profiles and their effects on MSCs mediated immunomodulation have 
become an important field of scientific research in recent years to comprehend 
possible encounters of TLR ligands with MSCs and their influence in inflammatory 
sites. Several studies have been performed on TLR expression profiles of human 
MSCs. The reported results presented different expressions of TLRs corresponding to 
the tissue origin of these cells. While bone marrow-derived MSCs showed an 
expression of TLRs 1, 2, 3, 4, 5, 6, 8, 9 and 10 [125, 186, 188], MSCs originating from 
the umbilical cord blood and Wharton jelly displayed the same results with an exception 
of TLR8, TLR10 [108, 230] and TLR4 [146, 186]. Investigations on oral tissue related 
MSCs, demonstrated an expression of all TLRs except TLR7 in periodontal ligament 
MSCs [125], besides TLRs 2, 3 and 4 in MSCs derived from dental follicle [28, 226] 
and dental pulp [226, 249]. Furthermore, the evidence has shown the possible 
modulation of this expression pattern by microenvironmental factors surrounding the 
MSCs. Inflammatory conditions have been suggested to upregulate the expression of 
TLR2 [188, 193], TLR4 [188, 205] and TLR7 [193]. On the other hand, TLR6 was 
downregulated under the same conditions [188]. Similarly, in human BM-MSCs viral 
infections [30, 32] and hypoxia [32] induced an increased expression of TLRs 1, 2 and 
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3 and TLRs 1, 2, 5, 9 and 10 respectively. Furthermore, fatty acids also showed a 
suppressive effect on TLR2 expression in mouse AD-MSCs [96].  
In many cases the consequence of TLRs’ activation on MSCs and the local immune 
reaction appears to be related to the origin of cells and the type of TLR activated. In 
recent studies, results have shown no significant change by TLR stimulation on human 
AD-MSCs [130], BM-MSCs [186], UCB-MSCs [230], and wharton jelly MSCs’ [186] 
immunosuppressive effect. Nevertheless, other scientific groups confirmed the support 
of human BM-MSCs mediated immunosuppression by TLR ligands in different 
mechanisms. In case of TLR3 and TLR4, some groups observed the increased 
immunosuppressive influence after TLR activation without correlation with IDO activity 
or PGE2 levels [40]. Others had dissimilar results presenting the indirect induction of 
IDO1 production as the main mechanism leading to the same effect by TLRs on BM-
MSCs [170]. In another investigation TLR3 and TLR4 ligands were reported to have 
reducing effects on human BM-MSCs mediated suppression of T-cell proliferation 
[129], whereas other investigations reported the opposite result through stimulated 
TLR3 and TLR4 with the same type of MSCs [170]. Moreover, TLR3 activation 
enhanced the suppressive role of DF-MSCs and DP-MSCs to the local immune 
response, while activated TLR4 promoted the immunosuppression in DF-MSCs and 
decreased it in DP-MSCs [226].  
In addition, TLRs of MSCs have shown the ability to trigger the production of pro- or 
anti-inflammatory cytokines regulating the immune response [244]. In consonance with 
this, the kinetics of TLR activation, besides the ligand concentration and timing, have 
been proposed as important factors controlling the cytokine release [244]. This function 
also seems to depend on the type of TLR and the origin of MSCs. Triggering of TLR4 
promoted the expression of pro-inflammatory molecules as IL-6 or IL-8. TLR3 
activation on the other hand enhanced anti-inflammatory functions by molecules as IL-
4, or IDO. These pro-inflammatory and anti-inflammatory mediators act in concert 
together, controlling the immune response against the invading pathogens. While pro-
inflammatory response increases the production and activation of immune cells and 
mediators, this process is counter-regulated by the anti-inflammatory cytokines on 
cellular and humoral levels [253]. 
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Even on lymphocyte proliferation level and its relation to TLR3 and TLR4 activation, 
the same pro- and anti- inflammatory influence was observed [244]. In regard to the 
tissue origin of TLR stimulated, MSCs, BM-MSCs and UCB-MSCs showed no changes 
in their cytokine production, while PL-MSCs showed a weaker immunosuppressive 
ability [24, 58]. 
MSC induced cytokine secretion by TLR activation has also an effect on neutrophils 
as another part of their immunomodulation. Investigations displayed that TLRs of BM-
MSCs delayed neutrophil apoptosis through cytokines as IL-6 and IFN-γ and increased 
their respiratory burst. This effect was confirmed in the same study by MSCs originating 
from adipose tissue, thymus and spleen [23]. 
Studies also reported the possible impact of activated TLRs on the differentiation 
potential of MSCs. Adipogenic differentiation showed no changes after UCB-MSCs 
and AD-MSCs‘TLR3 and TLR4 stimulation [98, 108, 130]. Alternatively, osteogenic 
differentiation of BM-MSCs, AD-MSCs and UCB-MSCs was intensified with TLRs 2, 3 
and 4 activation [98, 108, 130] and inhibited with TLR9 ligands [129, 130, 165]. 
Interestingly, chondrogenic differentiation showed only an enhancement with TLR2 
stimulation [108], while TLRs 3, 4 and 7 agonists had no obvious effect [129]. 
Considering the proliferation rate and migration of MSCs, inhibition of proliferation was 
observed with concurrent TLR9 activation [98]. In mouse BM-MSCs TLR2 and TLR4 
ligands increased the proliferative rate of the MSCs [179, 243]. Other studies 
performed on the migration of MSCs to injury sites after TLR stimulation showed no 
amplification of the MSCs’ movement [122, 179], except with stimulated TLR3 of 
human BM-MSCs [224].  
Concerning the TLR activation in MSCs and its relation to therapeutic benefit in vivo, 
different results have been published so far. Several studies reported therapeutic 
benefits of using LPS stimulated MSCs treating induced lung injury in animal models 
[74, 161, 162]. Other investigations about the survival and engraftment of MSCs for 
cardiac protection and its modulation by TLRs showed varying results. First, positive 
effects of TLR4 modulation of MSCs used for the treatment of acute myocardial 
infarctions were demonstrated in rats [252]. On the other hand a contrasting result was 
revealed by a different investigation [242]. In this regard it can be concluded, that 
various modulations affected by TLR stimulation on MSCs of different origins need 
Introduction and review of literature 
 
24 
 
further investigations in the future to clarify the importance of these factors and their 
role in possible therapeutic administrations of MSCs. 
 
1.4 Periodontium and periodontitis 
1.4.1 The healthy periodontium  
The periodontium forms the supporting structures surrounding every tooth. It consists 
of alveolar bone proper, cementum, periodontal ligaments and the gingival tissues, 
formed of connective tissue and epithelium. Besides supporting the teeth these 
structures also play a fundamental role of protection against different pathogens and 
in sensation of touch and pressure to the tooth [82, 155].  
The word incorporates two Greek terms peri- and -odons, meaning literally taken 
“around the tooth”. Various studies have investigated the structure of the periodontal 
apparatus in healthy conditions. Compassing a dimension of approximately 1mm the 
gingival epithelium is attached to the tooth 0.67-1mm apical to the cementoenamel 
junction (CEJ). The connective tissue of the gingiva forms the base for the epithelium 
and connects to the tooth a further millimetre apically. It mainly holds collagen, 
fibroblasts and ground substance. In an apical direction to the gingiva the alveolar bone 
proper continues the attachment to tooth through the periodontal ligament connecting 
between the alveolar bone proper and the cementum of the tooth root. Among the 
people, minor differences regarding the dimensions of these structures might occur 
[155]. The dimension of soft tissues attached to the tooth surface in coronal direction 
to the alveolar bone is called the “biologic width” [166]. Although the “biologic width” 
does not have a constant dimension and may vary between teeth and their aspects, it 
was reported that a dimension of 3 mm is enough to provide the needed functions and 
protection to the tooth and stay in a healthy condition for at least 6 months. In healthy 
conditions measurements of “biologic width” compose of approximately one millimetre 
each for the sulcus depth, epithelial attachment and connective tissue attachment 
[166].  
The functionalities of the periodontium vary between its different structures. The main 
role of the epithelium is to create a barrier against bacterial invasion into the soft and 
hard tissues of the periodontium. [155]. Moreover, the alveolar bone is the main 
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support of the tooth against the strong masticatory forces. These forces are additionally 
distributed through the periodontal ligaments, which also stabilize the tooth within its 
socket and supply it with nutrition and somatosensation [160]. 
 
1.4.2  The diseased periodontium  
Periodontal diseases include several inflammatory disorders affecting the 
periodontium. These conditions are cumulative and influenced by different factors that 
play major roles in defining the host response towards the disease [171]. Periodontitis 
is always preceded by gingival inflammation initiated by bacterial pathogens. Further 
development of the disease is then provided by host factors of every patient [110]. This 
interaction between acquired, environmental and genetic factors has been reported to 
be the main process affecting the host susceptibility to the periodontal inflammation 
and destruction [171]. 
Gingivitis starts by colonization of the gingival sulcus and surrounding surfaces by the 
bacterial pathogens. These form a structure called bacterial biofilm, sticking to the 
tissues and generating bacterial products as LPS which are recognized by Toll-like 
receptors of the gingival cells [136, 216]. This process activates an inflammatory 
response of the gingiva leading to the gingival disease. At early stages of the disease, 
mechanical removal of the biofilm and the tooth-tissue interface is the first step to treat 
the inflammation and prevent any progression of the disease [50]. If bacterial deposits 
are left to accumulate they start invading deeper structures of the periodontium and by 
the same process the destruction of the attachment apparatus is continued. As the 
junctional epithelium of the periodontium is destroyed, it detaches  from the tooth 
surface and can start an apical migration, exposing the root surface of the tooth to 
more inflammatory and bacterial insults and creating a periodontal pocket or recession 
[215]. 
Periodontitis can be classified into one of two main types, chronic and aggressive. In 
chronic periodontitis the tissue destruction is not continuous but shows periods of acute 
exacerbation causing the loss of periodontal attachment. This can be correlated to 
increased proportions of  so called periodontal pathogens including Porphyromonas 
gingivalis, Prevotella intermedia, Bacteroides forsythus, Aggregatibacter (formerly 
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Actinobacillus) actinomycetemcomitans and Treponema denticola [10]. On the other 
hand, aggressive periodontitis is characterized by rapid damage to the periodontal 
ligaments and the supporting bone. It may also display raised amounts of bacterial 
deposits of Aggregatibacter  actinomycetemcomitans and/or Porphyromonas 
gingivalis and secreted inflammatory molecules such as prostaglandin E2 (PGE2) and 
interleukin-1β [10, 61]. Although both types of periodontitis share a number of clinical 
features, aspects as the age of onset, clinical signs of correlated gingivitis, patterns of 
destruction and plaque and calculus formation are considered to differentiate between 
them [159]. While chronic periodontitis shows generalized or localized pattern of 
inflammation, usually aggressive periodontal inflammations affect a large number of 
teeth. In addition to that, younger ages of aggressive periodontitis patients and their 
fewer clinical signs of gingivitis are also points of contrast between the two types. 
 
1.4.3  Etiology and risk factors of periodontal disease 
Various reports provide scientific evidence that periodontal disease etiology can be 
associated with a large number of risk factors. These can be classified into modifiable 
factors as smoking, Diabetes and stress and non-modifiable factors as osteoporosis 
and blood disorders [7] Nevertheless, the main and most important etiology of 
periodontitis are the periodontal pathogens, including different species of bacteria 
coexisting together in mixed microbial infections of the periodontium [18, 185, 194]. 
While the oral cavity includes over 700 bacterial species, 400 among these are found 
in subgingival plaque [14, 175]. Further investigations specified only certain types to 
play major roles in the etiology of periodontitis [259]. Especially gram negative 
anaerobic rods and spirochetes are dominating species in deep periodontal pockets 
[78, 150]. Furthermore Porphyromonas gingivalis [112] and Aggregatibacter 
actinomycetemcomitans [46] have been associated with periodontal pathology. 
Moreover, Prevotella intermedia [131], Bacteroides forsythus [233] and Fusobacterium 
nucleatum [196] present important etiological factors of the disease progression. 
Capnocytophaga species [34], Peptostreptococcus micros [5, 190], as well as herpes 
viruses [39] were also reported in to have associations with periodontal disease. 
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Many studies have investigated the different factors characterizing these pathogens 
and their virulence towards the periodontium. In particular, Porphyromonas gingivalis 
[152], Aggregatibacter actinomycetemcomitans [2], Treponema denticola [211], 
Tannerella forsythia [157] and were intensively investigated by different research 
groups. These microorganisms are considered important pathogenic factors for 
periodontal diseases through a number of possible virulent mechanisms [94]. While 
agents as adhesins, invasins and bacteriocins promote colonization and persistence 
of the bacteria, other factors as, chemotactic inhibitors, leukotoxins, Fc-binding 
proteins and immunosuppressive proteins interfere with the host’s defences. 
Furthermore, cytotoxins, bone resorption agents, stimulators of inflammatory 
mediators and collagenase are responsible for the tissue destruction affecting the 
periodontium. In addition, host tissue repair is inhibited by inhibitors of bone formation 
and inhibitors of ﬁbroblast proliferation. Concerning these factors of virulence, the TLR 
signalling pathway is considered an element of great importance defining the 
pathogenicity of bacteria to periodontal tissues and correspondent responses of the 
body on local and systemic levels [11, 79] 
 
1.5 Aim of the thesis 
This study aims to describe for the first time the distinctive TLRs’ expression profile of 
G-MSCs in inflamed and uninflamed environments. As the oral cavity is habitat to a 
large number of bacterial species under physiological conditions and even clinically 
healthy marginal tissues of the periodontium can show histological signs of 
inflammation [27, 83], the regeneration of destroyed periodontal tissues has to be 
performed under the influence of inflammatory stimuli.  Changes occurring in the 
expression of TLRs responding to such stimuli could impact the therapeutic potential, 
regenerative capacity and immunomodulatory effects of G-MSCs in inflamed tissues 
in-vivo. 
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2 Materials and Methods 
2.1 Isolation and culture of G-MSCs 
2.1.1 Ethical committee approval and informed consents 
The current study was approved by the ethical committee of the Christian-Albrecht’s 
University of Kiel (IRB- Approval number D 444/10). Before excising the gingival 
samples needed for the study, an informed consent was obtained from every patient 
individually. 
 
2.1.2 Sample isolation  
G-MSCs isolation was done as previously described [51]. Free gingival collars from 
five individuals (n=5) were surgically excised at the department of periodontology of 
the Christian-Albrecht’s-University-Kiel, Germany. Instantly after surgery, every 
sample was placed in a 50 ml sterile polypropylene tube containing Minimum Essential 
Medium Eagle Alpha Modification (α-MEM; Sigma-Aldrich GmbH, Hamburg, Germany) 
supplemented with antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin) and 1% 
amphotericin (all from Biochrom AG, Berlin, Germany). The free gingival tissue collars 
were detached, de-epithelised and cut into small pieces (2 mm-3 mm) under the 
laminar flow hood. They were rinsed several times with Minimum Essential Medium 
Eagle Alpha Modification (α-MEM; Sigma-Aldrich GmbH, Hamburg, Germany) 
supplemented with antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin) and 1% 
amphotericin (all from Biochrom AG, Berlin, Germany) and placed into dry 75 ml culture 
flasks (Sarstedt AG, Nümbrecht, Germany) for 30 minutes to adhere to their bottoms. 
Subsequently, the basic medium consisting of α-MEM, supplemented with 15% fetal 
calf serum (FCS; HyClone, Logan, UT, USA), 400 mmol/ml L-glutamine (Biochrom), 
100 U/ml penicillin, 100 µg/ml streptomycin and 1% amphotericin was gently added. 
The flasks were incubated in 5% carbon dioxide at 37°C for 1 week without changing 
the medium and cells were left to grow out.  
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2.1.3 Cell culturing and isolation 
2.1.3.1 Gingival mixed cell culture 
Following the sample isolation procedure, the culture flasks were intermittently 
checked by phase contrast inverted microscopy to observe any outgrowing cells. The 
change of basic medium added to the flasks started 7 days after the placement of the 
samples into the flasks and was performed three times per week. This was continued 
until the outgrowing mixed cell culture reached 80-85% confluence. 
 
2.1.3.2 Cell passage 
After the cells reached a confluence of 80-85%, cells in the flasks were washed twice 
with 10 ml phosphate buffered saline (PBS) (Biochrom). Afterwards 5 ml of accutase 
(EMD Millipore) was added to each of the flasks which were then incubated in a 5% 
CO2 incubator at 37°C for 10 min to allow the cells to detach from the flasks’ bottom. 
Subsequently the cell suspensions were transferred to sterile Falcon tubes (Sarstedt) 
and centrifuged at 1700 rpm for 10 min. The supernatant was then removed and cells 
were resuspended in 2 ml of Minimum Essential Medium Eagle Alpha Modification, 
supplemented with 15% FCS, 4 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin and 1% amphotericin. Finally, the cells were counted and tested for 
viability with Trypan blue (Sigma-Aldrich) and seeded at a density of 30 cells/cm² in 75 
ml culture flasks. 10 ml of basic culture medium was added to each and the flasks were 
incubated in 5% CO2 at 37°C. Medium change occurred 3 times per week. 
 
2.1.3.3 Magnetic activated cell sorting (MACS) 
After the cells’ first passage reached 80-85% confluence, magnetic activated cell 
sorting (MACS) was done to isolate the G-MSCs from the mixed gingival cell culture. 
At first the medium within the flasks was aspirated and cells in every flask were washed 
twice with 5 ml of PBS. 5 ml of accutase were then added to each culture flask and the 
flasks were incubated in 5% CO2 incubator at 37°C for 5 min to detach the cells from 
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the flasks. These cells were then transferred to new falcon tubes and centrifuged for 5 
min at 1500 rpm. This allowed the supernatant to be easily discarded and the cell pellet 
was resuspended in 10 ml of fresh basic medium. Furthermore, a cell count was 
performed and the cell suspension was again centrifuged for 5 min at 1500 rpm to 
discard the supernatant and subject the cells to the MACS technique for MSCs’ 
isolation.  
 
2.1.3.3.1.1.1 MACS Separator and MACS column preparation  
First of all the magnetic field was disinfected with 70% ethanol and the column attached 
to the magnetic field of the MACS Separator according to manufacturer’s instructions 
(Miltenyi Biotec, Bergisch-Gladbach, Germany). The column was prepared by rinsing 
it with 500 µl MACS-buffer consisting of 0.5% bovine serum albumin (BSA) and 2 mM 
EDTA in PBS (all from Biochrom). Two tubes were labelled and prepared to receive 
the cells below the column; one for MACS positive and one for MACS negative cell 
populations 
 
2.1.3.3.1.1.2 Magnetic labelling  
After incubating the cells with r FcR- blocking reagent (Miltenyi Biotec) for 5 min, anti 
STRO-1 (BioLegend, San Diego, CA) and anti IgM Micro Bead antibodies (Miltenyi 
Biotec) were added to the cells afterwards according to manufacturer’s instructions for 
10 min at 4 ºC. Ten times MACS-buffer volume was added to the cell suspension and 
the suspension centrifuged for 10 min at 1700 rpm at 4 ºC. The supernatant was 
discarded and the resultant cell pellet resuspended in 500 µl MACS-buffer (cells< 108) 
or 1000 µl MACS-buffer (cells>108) (Fig. 5). 
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2.1.3.3.1.2 Magnetic separation 
The magnetic labelled and resuspended cells were transferred to the MACS Column 
to start the separation procedure (Fig. 6). Cells that passed through the column were 
collected by the MACS negative labelled tube. 500 µl MACS-buffer was then added 
three times to the column to perform the washing step and new buffer was only added 
when the column reservoir was empty. Following that the column was removed from 
the separator and positioned on the MACS positive collection tube. 1 ml of MACS 
buffer was pipetted into the column and the buffer with the cells within the column were 
eluted by a provided plunger into the MACS positive labelled tube. The obtained MACS 
positive cells were filled with MACS buffer to a volume of 5 ml. The MACS positive cell 
count was performed and their cell suspensions were centrifuged for 10 min at 1700 
rpm at 4 ºC to seed the MACS positive cells out to form colony forming units (CFUs). 
 
Source: http://www.miltenyibiotec.com/en/products-and-services/macs-cell-
separation/cell-separation-reagents/any-cell-type.aspx 
Figure 5: Schematic image of MSC surface after magnetic labelling with Microbeads 
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2.2 Colony-forming units (CFUs)  
To assess the cells’ efficiency to form colonies, MACS positive (G-MSCs) were 
cultured in basic medium at a density of 1.63  cells/cm2. Aggregates of 50 or more cells 
were scored as colonies. On day 12 a representative sample of the cultures were fixed 
with 4% formalin, stained with 0.1% crystal violet. From the remainder of the CFUs 
forming G-MSCs single colonies were then detached by cell scrapers [71, 117] and 
seeded in new 75 ml flasks in basic medium to grow.  
 
2.3 Flow cytometric analysis predefined MSCs’ surface markers) 
After reaching 80%-85% confluence, a sample of the G-MSCs were characterized by 
flow cytometry for the predefined MSCs’ surface marker constellation [47]; namely 
CD14, CD34, CD45, CD73, CD90 and CD105 (all from Becton Dickinson). Primary 
antibodies’ reaction with the corresponding isotype controls was performed according 
to standard protocols using FcR Blocking Reagent (Miltenyi Biotec) and finally 
Source: http://www.miltenyibiotec.com/en/products-and-services/macs-cell-
separation/macs-technology/microbeads_dp.aspx 
 
Figure 6: Magnetic sorting of labelled MSCs through MACS technique 
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evaluated with FACSCalibur E6370 and FACSComp 5.1.1 software (Becton 
Dickinson).  
 
2.4 Multilineage differentiation potential 
Cells obtained by the isolation procedures were tested independently for their 
multilineage differentiation ability into osteogenic, adipogenic and chondrogenic 
lineages. Cells at their third passage were cultured on 6-well culture plates (Sarstedt, 
Germany) for osteogenic and adipogenic differentiations and in 96-well plates 
(Sarstedt, Germany) for chondrogenic differentiations with specific inductive media. 
 
2.4.1 Osteogenic differentiation 
To investigate the osteogenic differentiation potential, third passage 2×104 G-MSCs 
were cultured on 6-well culture plates in osteogenic differentiation inductive medium 
(Promo Cell, Heidelberg, Germany). As control cells, G-MSCs were cultured in basic 
medium. At day 14, cell cultures were stained with Alizarin Red (Sigma-Aldrich) [47], 
to mark calcified deposits and evaluate the staining qualitatively.  
 
2.4.2 Adipogenic differentiation 
To test the adipogenic differentiation potential, 3×105 G-MSCs of the third passage 
were cultured on 6-well culture plates in adipogenic differentiation inductive medium 
(Promo Cell). As a control G-MSCs were cultured in basic medium. The existence of 
lipid drops was evaluated by staining with Oil-Red-O (Sigma-Aldrich) qualitatively [47].  
 
2.4.3 Chondrogenic differentiation 
To test the differentiation potential of the cells in a chondrogenic direction, micro-
masses of third passage 3×104 G-MSCs were incubated with chondrogenic 
differentiation inductive medium (Promo Cell) in 96-well culture plates with rounded 
bottoms (Sarstedt AG, Germany). As a control, G-MSCs were cultured in basic 
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medium. Chondrogenic differentiation was assessed qualitatively at day 21 by staining 
of glycosaminoglycans with Alcian Blue (Sigma-Aldrich) [47, 127]. All media were 
renewed three times per week. 
 
2.5 Inflammatory medium 
To test the result of the inflammatory environment on the G-MSCs, TLR expression 
profile, a combination of 25 ng/ml IL-1β, 103 U/ml IFN- γ, 50 ng/ml TNF-α, and 3×103 
U/ml IFN-α (inflammatory medium, all from PeproTech, Hamburg, Germany) [189] was 
used. G-MSCs were incubated for 18 hours in the inflammatory medium (G-MSCs-i) 
as well as basic medium (G-MSCs). 
 
2.6 Flow cytometric determination of TLR expression  
G-MSCs and G-MSCs-i were characterized by flow cytometry for the presence of the 
different TLRs 1-10 at protein level. The following antibodies were used: anti-TLR1, 
anti-TLR3 and anti-TLR9 (all from eBioscience), anti-TLR2, anti-TLR4 and anti-TLR8 
(all from Enzo Life Sciences, Lörrach Germany), anti-TLR5 (R&D Systems, Hessen, 
Germany), anti-TLR6 (BioLegend), anti-TLR7 (Perbio Science, Bonn, Germany) and 
anti-TLR10 (Acris Antibodies, Herford, Germany). The antibodies and their isotype 
controls were each conjugated with PE, FITC or Alexa Flour 488 fluorescent dyes. For 
intracellular TLRs staining, cells were first fixed and permeabilized with Fix & Perm cell 
permeabilization kit (BD Biosciences) before adding the antibodies and their isotype 
controls to the cells. The addition of the primary antibodies and the corresponding 
isotype controls was performed according to standard protocols by first adding FcR 
Blocking Reagent (Miltenyi Biotec) to each sample tube, followed by the specific 
antibodies or isotype controls according to the protocol. Finally the samples were 
evaluated with FACSCalibur E6370 and FACSComp 5.1.1 software (Becton 
Dickinson).  
The following sample protocol (13 FACS tubes for each cell line) was used for TLR-
antibody FACS preparation: 
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 Extracellular TLRs: 
1) Anti TLR1 PE (5 µl = 1 µg) + anti TLR2 FITC (10 µl = 1 µg) 
2) PE Mouse IgG1 (5 µl = 1 µg) + FITC Mouse IgG2a (1 µl = 1 µg) 
3) Anti TLR4 FITC (2 µl = 2 µg) + anti TLR10 PE (2 µl = 1 µg) 
4) FITC Mouse IgG2a (2 µl = 2 µg) + PE Mouse IgG2 (0.1 µl = 1 µg) 
5) Anti TLR5 Alexa Fluor 488 (5 µl = 0.5 µg) + anti TLR6 PE (5 µl = 1 µg) 
6) Alexa Fluor 488 isotype ctrl (5 µl = 0.5 µg) + PE Mouse IgG1K isotype ctrl (5 µl = 1 
µg) 
 Intracellular TLRs: 
7) Rat IgG1k PE isotype ctrl (0.5 µl = 0.1 µg) 
8) Rat IgG1k PE isotype ctrl (5 µl = 1 µg) 
9) Anti TLR3 PE (5 µl = 1 µg) 
10) Anti TLR7 PE (2 µl = 0.1 µg) 
11) Anti TLR8 PE (2 µl = 1 µg) 
12) Mouse IgG2ak PE isotype ctrl (20 µl = 2 µg) 
13) Anti TLR9 PE (10 µl = 2 µg) 
 
2.7 TLR gene expression profile  
2.7.1  m-RNA Extraction and cDNA Synthesis 
m-RNA extraction was completed for G-MSCs and G-MSCs-i using the RNeasy kit 
(Qiagen, Hilden, Germany). At first the medium was aspirated off the culture wells and 
each well was washed twice with 5ml of PBS. After that the cells were scraped in PBS 
and 300 μl of buffer RLT with β-mercaptoethanol was added to each well after scraping 
leading to cell lysis. Afterwards 300 μl of 70% ethanol was supplemented to the lysate 
in each well and mixed well by proper pipetting. Each sample was then pipetted onto 
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an RNeasy mini column rested in collection tube of 2 ml volume. The tube was closed 
and centrifuged for 30 seconds at 10000 rpm. The flow through within the collection 
tube was discarded after the centrifugation and the tube was replaced by a new one. 
Moreover 700 μl Buffer RW1 was pipetted onto each RNeasy column and again 
centrifuged for 30 seconds at 10000 rpm. After discarding the flow through and 
replacing the collection tube 500 μl Buffer RPE was applied into each RNeasy column 
and centrifuged for 30 seconds at 10000 rpm. Finally, the flow through was removed, 
the columns relocated to new 1.5 ml collection tubes and 30–50 μl RNase-free water 
directly applied onto the RNeasy silica-gel membrane. This was followed by the last 
centrifugation step for 1 minute at 10000 rpm to collect the RNA in the 1.5 ml collection 
tubes. The collected RNA was purified afterwards utilizing RNase-free-DNase 
(Promega, Mannheim, Germany), and photometrically quantified. 
 
2.7.2 Reverse transcription and real time polymerase chain reaction (rt-PCR) 
Complementary cDNA was produced from 1-13 µl of RNA (1 µg/µl) by reverse 
transcription (RT) utilizing QuantiTect reverse transcription kit (Qiagen) according to 
the manufacturer’s instructions (Mastercycler gradient; Eppendorf) in a volume of 20 
µl reaction mixture containing 4 pmol of each primer, 10 µl of the LightCycler Probes 
Master mixture (Roche Diagnostics) and 5 µl specimen cDNA. To diminish the risk of 
RNA degradation all reactions were set up on ice. The reverse transcription reaction 
consisted of the following components according to table 1. 
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Table 1: Reverse-transcription reaction components 
 
Before adding the aliquots of every completed reverse-transcription reaction to the 
real-time PCR mix, tubes containing reverse-transcription master mix and template 
RNA were incubated for 15 min at 42°C, then for 3 min at 95°C to disable Quantiscript 
Reverse Transcriptase. 
Real time polymerase chain reaction (rt-PCR; LightCycler 96 Real-Time PCR System, 
Roche Molecular Biochemicals, Indianapolis, Indiana, USA) was completed according 
to the manufacturer’s instructions. Cycling conditions were as follows: 95°C for 10 
minutes to achieve initial denaturation and activation of Taq polymerase (pre-
incubation). Then the cycling continues by 45 thermal cycles of 95°C for 10 seconds, 
60°C for 30 seconds, and 72°C for 1 second, with a ramping rate of 4.4°C/second, 
2.2°C/second, and 4.4°C/second, respectively (amplification). Following the 
amplification process the plates were cooled to 40°C for 30 seconds. Fluorescence 
was observed continuously throughout the melting procedure.  
Relative quantities of each transcript were normalized according to the expression of 
PGK1. Primers for TLRs 1 to 10 and the reference gene PGK1 were supplied by Roche 
and tested on G-MSCs and G-MSCs-i (Table 2). 
 
 
Component Volume/reaction Final concentration 
Reverse-transcription master 
mix 
 Quantiscript Reverse 
Transcriptase 
 Quantiscript RT Buffer, 
5x (includes Mg2+ and 
dNTPs and RNase 
inhibitor) 
 RT Primer Mix (includes 
Mg2+ and dNTPs) 
 
 
1 µl 
4 µl 
 
1 µl 
 
 
 
1× 
 
Template RNA 
 Entire genomic DNA 
elimination reaction 
 
14 µl 
 
Total volume 20 µl  
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Table 2: Primer names and ID used for real-time PCR 
Assay ID Gene Symbol Accession ID 
111000 TLR1 H. sapiens ENST00000308979 
145617 TLR2 H. sapiens ENST00000260010 
111008 TLR3 H. sapiens ENST00000296795 
135752 TLR4 H. sapiens ENST00000355622 
103674 TLR5 H. sapiens ENST00000366881 
111018 TLR6 H. sapiens ENST00000381950 
111012 TLR7 H. sapiens ENST00000380659 
103816 TLR8 H. sapiens ENST00000218032 
143252 TLR9 H. sapiens ENST00000360658 
141065 TLR10 H. sapiens NM_001017388 
102083 PGK1 H. sapiens ENST00000373316 
  
2.8 Statistical analysis 
To test normal distribution of the data the Shapiro-Wilk-Test was used. Differences in 
TLRs’ expression on m-RNA and Protein levels in G-MSCs and G-MSCs-i were 
evaluated using the nonparametric Wilcoxon Signed Rank test using SPSS software 
(SPSS version 11.5, SPSS, Chicago, IL). The level of significance was set at p=0.05 
as the expression of each TLR in the non-inflammatory condition was compared to its 
expression under inflammatory stimuli. 
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3 Results 
3.1 Phase contrast inverted microscopy and colony forming units  
Subsequent to the adherence of the tissues, cells grew out of the fragments of gingival 
tissues, forming fibroblast-like clusters adherent to the surface (Fig.7A). The expanding 
cell cultures were regularly examined every 24 hours by the phase contrast inverted 
microscopy. Twelve days after seeding of the MACS positive cell population of each 
cell line, G-MSCs displayed CFUs (Fig. 7B).  
 
Figure 7: Microscopic display and colony-formation of G-MSCs. (A) Phase contrast 
microscopic display of the adherent tissue fragment with new outgrowing cells (2nd 
week). (B) Colony-forming units of G-MSCs (crystal violet). 
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3.2 Flow cytometric analysis (predefined MSCs’ surface markers) 
With regard to the flow cytometric analysis following the magnetic cell sorting to inspect 
characteristic markers of MSCs, cells derived from the G-MSCs isolation protocol 
showed negative results for CD14, CD34 and CD45, while positive expressions were 
presented for CD73, CD90 and CD105 (Fig.8). 
 
 
3.3 Multilineage differentiation potential 
Osteogenic differentiation of G-MSCs was shown by the formation of sediments of 
calcification marked with Alizarin Red dissimilar to their controls (Fig.9). Adipogenic 
differentiation of G-MSCs resulted in the development of lipid droplets that could be 
positively stained with Oil-Red-O dissimilar to their controls (Fig. 10). Chondrogenic 
differentiation of G-MSCs resulted in the generation of glycosaminoglycans that could 
be positively stained with Alcian Blue dissimilar to their controls (Fig.11).  
 
Figure 8: Flow cytometric analysis of characteristic surface marker expression profile of G-MSCs 
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3.3.1 Osteogenic differentiation potential 
G-MSCs were cultured on 6-well culture plates in an osteogenic differentiation 
inductive medium. After 2 weeks, the formation of calcified sediments was observed, 
by Alizarin Red staining. This calcium formation displayed the osteogenic 
differentiation of the isolated G-MSCs. In contrast, the control cells lacked any 
osteogenic differentiation and did not show any formation of Alizarin Red-positive 
deposits (Fig.9). 
 
 
3.3.2 Adipogenic differentiation potential 
G-MSCs were cultured on 6-well culture plates in an adipogenic differentiation 
inductive medium. After 3 weeks, the development of lipid droplets was seen, by Oil 
Red O staining. This lipid formation displayed the adipogenic differentiation of the 
isolated G-MSCs. In contrast, the control cells presented very weak or lacked any 
adipogenic differentiation and Oil Red O stained droplets (Fig.10). 
 
 
Figure 9: Alizarin Red staining of the osteogenically stimulated MACS+ G-MSCs and 
their controls 
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3.3.3 Chondrogenic differentiation potential 
G-MSCs were cultured on 96-well plates with rounded bottoms in a chondrogenic 
inductive medium. After 3 weeks, the presence glycosaminoglycans was demonstrated 
by Alcian Blue staining. This glycosaminoglycans formation displayed the 
chondrogenic differentiation of the isolated G-MSCs. In contrast, the control cells 
displayed very weak or lacked any chondrogenic differentiation and Alcian Blue stained 
particles (Fig.11). 
Figure 10: Oil-Red-O staining of the adipogenically stimulated MACS+ G-MSCs and 
their controls 
Figure 11: Alcian Blue staining of the chondrogenically stimulated MACS+ G-MSCs 
and their controls 
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3.4 Flow cytometric TLR expression  
Evaluation of the prepared samples for TLR expression on protein level was performed 
with FACSCalibur E6370 and FACSComp 5.1.1 software (Becton Dickinson). MSCs 
incubated in basic medium expressed TLRs 1, 2, 3, 4, 5, 6, 7 and 10 (Table 3 and 
Fig.12). The inflammatory medium significantly (Wilcoxon Signed Ranks Test) up-
regulated the expression of TLRs 1, 2, 4, 5, 7, and 10, while TLR6 was no longer 
expressed on G-MSCs-i (Table 3 and Fig.13). No difference was noted for the 
expression of TLR3 in both media. Both G-MSCs and G-MSCs-i did not express TLRs 
8 and 9. 
 
Table 3: Median Fluorescence Intensities, Q25/Q75 and p-values of expressed TLRs 
on protein level in G-MSCs and G-MSCs-i 
 
 
 
TLRs expression 
G-MSCs 
Median Fluorescence 
Intensity, Q25/Q75 
Significantly upregulated 
G-MSCs-i 
Median Fluorescence 
Intensity, Q25/Q75 
and p-value 
1 8.12, 3.91/11.33 
25.82, 18.37/37.92  
 p=0.043 
2   26.33, -2.21/41.72 
280.51, 213/354.90   
p=0.043 
3 5.79, 0.23/15.90 no significant changes 
4 13.89, 12.92/22.63 
105.19, 91.46/120.83  
p=0.043 
5 7.16, 5.43/15.67 
242.84, 216.80/287.38  
p=0.043 
6 3.25, 0.53/11.73 no expression 
7 7.83, 5.48/9.74 
24.41, 17.08/38.39  
 p=0.043 
8 no expression no expression 
9 no expression no expression 
10 1.16, -6.70/14.96 
55.83, 51.32/96.44 
  p=0.043 
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 . 
Figure 12: Median Fluorescence Intensity (MFI) of expressed TLR1 to 
TLR10 of G-MSCs (green curve) and of their isotype controls (red curve) 
after incubation in basic medium. Differences in fluorescence intensity of 
TLR1 to TLR10 (n=5; box- and whisker plots with medians and quartiles). 
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3.5 TLRs’ m-RNA expression 
Figure 13: Median Fluorescence Intensity (MFI) of expressed TLR1 to TLR10 
of G-MSCs (green curve) and of their isotype controls (red curve) after 
incubation in inflammatory medium. Differences in fluorescence intensity of 
TLR1 to TLR10 (n=5; box- and whisker plots with medians and quartiles). The 
green coloured boxes show significantly changed MFI after stimulation by the 
inflammatory medium. 
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TLR expression on m-RNA level inspected by rt-PCR presented the following: 
G-MSCs incubated in basic medium expressed TLRs 1 2, 3, 4, 5, 6, 7, 8 and10 (Table 
4 and Fig. 14A). G-MSCs-i showed a significantly higher expression (Wilcoxon Signed 
Ranks Test) of TLRs 1, 3 and 7, in addition to downregulated TLRs 6 and 10 (Table 4 
and Fig.14B). 
 
Table 4: Median gene copies/PGK2copies, Q25/Q75 and p-values of expressed 
TLRs on m-RNA level in G-MSCs and G-MSCs-i 
 
 
TLRs m-RNA 
expression 
G-MSCs 
Median gene 
copies/PGK2copies,Q25/Q75 
Significantly upregulated 
G-MSCs-i 
Median gene 
copies/PGK2copies,Q25/Q75 
and p-value 
1 0.0037, 0.0005/0.0171 
0.0172, 0.0094/0.0611, 
 p=0.043 
2 0.0035, 0.0002/0.0175 no significant changes  
3 0.0091, 0.0065/0.0678 
0.0629, 0.0449/0.1805, 
 p=0.043 
4 0.0118, 0.0000/0.0760 no significant changes  
5 0.0001, 0.0000/0.0001 no significant changes  
6 0.0018, 0.0004/0.0085 no expression 
7 0.0000, 0.0000/0.0001 
0.0015, 0.0011/0.0022, 
 p=0.043 
8 0.0000, 0.0000/0.0003 no expression 
9 no expression no expression 
10 0.0000, 0.0000/0.0002 no expression 
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Figure 14: Expression of TLR m-RNA after incubation in basic medium (A) and 
inflammatory medium (B). Relative quantities of TLR m-RNA expression normalized 
according to the expression of PGK1. The green coloured boxes show significantly 
changed m-RNA expression after stimulation by the inflammatory medium. 
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4 Discussion  
The development of inflammatory responses follows most tissue injuries and is 
considered a major part of the healing process in its early stages. Periodontal tissues 
show histologically pre-inflammatory circumstances, even under clinically healthy 
conditions or after a successful anti-inflammatory periodontal treatment [155]. 
Regarding this biological evidence in the field of tissue engineering and during possible 
therapeutic approaches, G-MSCs’ transplantation may be employed directly into 
inflamed milieus [57, 256], exhibiting the cells to inflammatory incitements and resulting 
conclusively in a direct communication between the G-MSCs and the PAMPs through 
their TLRs. Subsequently, the inflammatory stimulus and the TLR-PAMP interface 
affects the MSCs mediated immunomodulation as well as its reparative functions [134]. 
The aim of the present study was to characterize for the first time the distinctive TLRs’ 
expression profile of G-MSCs in inflamed as well as in uninflamed conditions as a first 
stage of exploring this possible interaction. 
4.1 Methods 
4.1.1 Tissue and G-MSCs’ isolation and identification 
For many years, most of the procedures used to extract and isolate MSCs from donor 
tissues have been associated with major surgical operations under general 
anaesthesia, a high ratio of donor site morbidity, painful harvesting or in some cases 
infection and loss of teeth [147, 153]. Regarding these risks and burdens on the 
patient, El-Sayed et al. established and patented a minimally invasive technique to 
isolate MSCs from gingival tissues and alveolar bone proper [52, 56]. In further animal 
experiments the periodontal regenerative potential of these cells was reported to be 
successful [54, 55]. Building upon these results the same technique was used in the 
present study to isolate G-MSCs from the collected gingival tissues. As proposed in 
the same studies by El-Sayed et al, the isolated gingival tissues were not digested 
enzymatically afterwards by collagenase in comparison to other investigations [44], 
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but relied on the tissue adherence to the culture dishes to avoid immense mechanical 
manipulation to the tissues and the outgrowing cultured cells.  
 
To determine the criteria needed for the identification of MSCs derived from the 
cultured tissues and to differentiate them from other cells outgrowing from the samples 
as fibroblasts, the study design was based on the standards of MSC identification as 
described by Dominici et al. in their position paper in 2006 [48] and confirmed by 
different research groups in their investigations [55, 255]. Following these criteria, the 
G-MSCs displayed in the present study were only accepted being plastic adherent 
under normal culture conditions, expressing the surface markers CD73, CD90, and 
CD105, with minimal or no expressions of CD45, CD34 and CD14, in addition to 
demonstrating the ability to form CFUs. 
 
Moreover, the G-MSCs had to be able to differentiate into the osteoblastic, 
chondroblastic and adipocytic lineages after stimulation by specialized differentiating 
media. 
 
For isolating potential G-MSCs from the tissue outgrowing gingival cells, anti-STRO-1 
antibodies and anti-IgM Micro Bead antibodies were applied during the magnetic 
activated cell sorting technique (MACS), similar to the procedures utilised in other 
investigations reporting the isolation of MSCs from alveolar bone proper [56], gingiva 
[54] and bone marrow aspirate [77]. The MACS separator, the device used to perform 
this type of cell sorting, depends on magnetic columns of cell separation which are 
needed for the attachement of marked cells in a magnetic field created by an external 
magnet that can be attached to the device. These columns contain a matrix of 
ferromagnetic substance that has the function to direct and focus the lines of the 
magnetic field and create potent gradients that are able to attract magnetized cells and 
bind them to the ferromagnetic matrix. In the present study, this process of cell isolation 
depends on the physical fact that anti STRO-1 antibodies bind to the required MCSs 
expressing the STRO-1 receptor conjointly with anti-IgM Micro Bead antibodies and 
therefore can successively be attracted by the magnetic field of the MACS separator 
and attached to the matrix within the separating column. Following that, the marked 
cells are eluted outside the magnetic field, where the ferromagnetic matrix of the 
MACS column is not able to hold the cells. Although this technique shows great ability 
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to isolate STRO-1 expressing cells in a simple and rapid procedure it is still not able 
to provide a MSCs’ culture of complete purity when the cells are isolated from mixed 
cell populations. 
 
4.1.2  Multilineage differentiation and colony forming units (CFU) assay 
Two other major criteria used in this investigation to identify the isolated MSCs were 
the ability of the cells to differentiate into the osteoblastic, chondrogenic and 
adipogenic directions and to form colony forming units (CFUs), distinguishing the 
MSCs from morphologically analogous fibroblasts [48, 56].  
 
The multilineage differentiation potential was tested by adding specialized inductive 
media to initiate the cell differentiation process into the three lineages. The 
composition of these media was decided according to standard investigations in the 
literature and the protocol of differential staining, as published by the International 
Society for Cellular Therapy, was used as a proof for positive differentiation of the cells 
[48, 56]. Calcified deposits were stained with Alizarin red, lipid droplets with  
Oil Red O and glycosaminoglycans with Alcian Blue to demonstrate the successful 
differentiation into the three mentioned lineages. 
 
Furthermore, to test the G-MSCs’ forming ability of CFUs the cells had to be able to 
form multiple single clusters of fibroblast-like cells in comparison with fibroblasts 
lacking this characteristic under the same culture conditions [52]. By the rise of these 
colonies from each of the MSCs the capabilities of these cells for self-replication and 
generation of clonogenic daughter cells can be clearly demonstrated. 
4.1.3 Analysis by flow cytometry 
The laser based technology of flow cytometry is a technique employed in cell sorting 
and counting, in addition to detecting biomarkers and microscopic particles, such as 
cell surface receptors. It allows a synchronized analysis of thousands of particles 
within seconds and an evaluation of their physical and chemical characteristics 
according to multiple parameters. The cellular investigations are based on the concept 
of coating the analysed cells with fluorescent labelled antibodies and suspending them 
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in a fluid. During the “real time” data acquisition the narrow liquid stream containing 
the cells is passed through the device rapidly. This torrent of cells is broken down into 
individual droplets by a vibrating mechanism, decreasing the probability of having 
more than one cell in every single droplet. When the stream passes through an optical 
detection apparatus, a laser beam is directed onto the cellular units inside the running 
fluid. This allows every suspended particle between 0.2 and 150 μm in size to scatter 
the aimed ray, while fluorescent molecules within or attached to the cells become 
excited and emit their fluorescence subsequently. Several detectors aimed at the liquid 
stream passing channel and surrounding it are then able to detect the combination of 
scattered and fluorescent light and analyse it. According to the fluctuations of light 
brightness picked up by every detector it is possible afterwards to develop the data 
needed about physical and chemical properties of the examined particles. 
 
Considered a proven technique for studying cellular populations with high precision 
[181], flow cytometry was utilised in this study to investigate two different aspects of 
the examined cell population. First of all, it was applied to characterize positive or 
negative expressions of MSC characteristic surface markers of the MSCs isolated from 
the collected gingival samples. As stated before, choosing these selected markers 
including CD14, CD34, CD45, CD73, CD90 and CD105 constructs on the position 
paper of Dominici et al. and other recent publications [48, 52, 55], presenting them as 
one of the important minimal criteria defining mesenchymal stem cells. Corresponding 
to this identification criteria, MSCs should display positive expressions of CD73, CD90 
and CD105, whereas lacking the receptors of CD14, CD34 and CD45 or expressing 
them very scarcely. 
 
To clarify the negative expression of the latter three markers on MSCs, investigations 
postulated CD14 to be normally expressed on cells of the innate immunity as 
monocytes, macrophages and neutrophil granulocytes [250], while CD34 is mainly 
expressed on early [173] and CD45 on differentiated cells of the hematopoiesis [22]. 
Moreover, the flow cytometric analysis was performed to explore the TLRs expression 
profile of G-MSCs on protein level in inflamed and non-inflamed environments. 
Similarly, this was the technique of choice in multiple studies inspecting TLRs of MSCs 
and other cell types [128, 193, 213, 224]. Nevertheless, exploring the TLRs of G-MSCs 
by flow cytometry provided only the evidence needed on protein level without an 
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assessment of the TLRs’ m-RNA condition within the cells, leading consequently to 
the introduction of the polymerase chain reaction (PCR) analysis to the study protocol 
to enable the assessment of TLRs’ m-RNA levels in inflamed and non-inflamed 
milieus. 
 
4.1.4  Analysis by real time polymerase chain reaction (rt-PCR) 
The polymerase chain reaction is a technique of molecular biology, generating an 
enzymatic process of DNA ampliﬁcation, which allows to some extent the mimicking 
of in vivo DNA replications through a series of cycles of the reaction. This technique, 
considered as one of the revolutionary scientiﬁc ideas of the 20th century [234], solved 
an essential problem faced by biologists for a long time, a method to achieve a de 
novo synthesis of DNA in vitro, hence providing the ability to amplify any required DNA 
target sequence, which normally has a concentration too scarce for downstream 
analysis. 
 
In optimal reaction conditions for the PCR, the quantity of the target DNA fragment of 
the inspected sample can be doubled in every cycle of the process, promoting an 
exponential accumulation of the reaction product. When the newly synthesized 
molecules have been produced sufficiently, ﬂuorescent dyes are utilised to visualize 
the created amplicons. In fact, the sensitivity of the PCR technique is so high, that only 
one molecule could be detected in a complex sample of DNA. 
 
Among the PCR technology, the technique of real-time PCR provided another step of 
advance in the area of DNA analysis. Compared to the conventional PCR technique, 
this advanced version allows a stronger quantitative and qualitative analysis, as well 
as highly sensitive amplification reactions of the sample DNA. As the process of DNA 
ampliﬁcation occurs this advanced technique gives biologists the ability to observe it 
as it happens. This key feature of the rt-PCR is possible, as the enzymatic reaction 
and detection process of the PCR amplicons both take place in the same PCR reaction 
vessel. 
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For monitoring the rt-PCR process a special equipment is needed, the Light Cycler, 
which performs an online data collection of PCR products from each cycle of the 
reaction. This measurement is enabled by means of fluorescent dyes which fluoresce 
on binding to DNA. The dye-DNA contact may be achieved directly, using intercalating 
dyes that attach to the double stranded DNA molecule, as SYBR Green I, as well as 
indirectly through ﬂuorescence-labeled oligonucleotides. These ﬂuorescent 
oligonucleotide probes can identify and bind to a speciﬁc site on one strand of the DNA 
molecule by a base pairing process. Following that, the measurement of the 
ﬂuorescence of the tested samples at every cycle of the PCR provides the possibility 
to display the accumulation of the reaction product on a plotted curve. As the amount 
of fluorescence measured by the device is proportional to the quantity of the PCR 
product in the Light Cycler, the time and number of cycles needed to provide 
detectable signals on the plotted curve increase when the initial concentration of the 
product is low in the inspected PCR sample. Subsequently, the data of cycle numbers 
can be easily used for qualitative and quantitative analysis of the explored gene. 
 
In the present investigation, the LightCycler 96 Real-Time PCR System from Roche 
Molecular Biochemicals was applied to inspect the expression of TLRs’ m-RNA in G-
MSCs, with or without inflammatory stimuli. The real time reaction was performed by 
using fluorescent probes and the fluorescence was monitored throughout the rt-PCR 
process. In several other investigations on MSCs, PCR analysis was employed to 
explore the m-RNA expression of different TLRs [40, 179, 193]. Hereafter, it seemed 
important in this study to examine the TLR expression profile on m-RNA, as well as on 
protein levels. This might even be necessary, as m-RNA and protein expression levels 
of the same gene do not always correlate or reflect each other, but could actually 
present conflicting results in some cases [1, 137, 236]. Accordingly, some investigators 
explained, that the link between both levels of gene expression is subjected to a 
number of technical and biological factors, leading to such discrepancy [137, 236]. 
Looking upon the possibility of the preceding postulations regarding the TLR genes, 
this study combined both expression levels of TLRs in G-MSCs to cover the whole 
spectrum of G-MSCs’ TLRs and provide a detailed and evident picture of their 
expression in inflamed and non-inflamed milieus. 
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4.2 Results 
As seen in previous investigations [51, 57], the characteristic stem cell marker, STRO-
1, was capable of isolating and purifying BM-MSCs [76] and alveolar bone proper-
derived stem/progenitor cells [53] using an immunomagnetic technique for cell 
selection. This technique has been exploited to isolate the G-MSCs. The characterized 
G-MSCs showed all classical features defined for MSCs [47, 65], being positive for 
CD105, CD73, CD90, while negative for, CD45, CD14 and CD34 as well as 
demonstrating a remarkable CFUs ability, plastic adherence and a multilineage 
differentiation ability into lineages of osteogenic, adipogenic and chondrogenic nature.  
In previous studies MSCs showed sensitivity to inflammation [38, 88, 187, 189]. In the 
current study, G-MSCs were cultured in an inflammatory medium supplemented with 
IL-1β, IFN- γ, TNF-α, and IFN-α, the cytokines mostly active at sites of inflammation 
[187], as well as in basic medium. This change of milieu surrounding the G-MSCs 
showed influential outcomes affecting the cells and their expression profile of TLRs. 
On protein level, the G-MSCs in uninflamed condition distinctively expressed a TLR 
profile of TLRs 1, 2, 3, 4, 5, 6, 7 and 10 in different amounts without TLR8 and TLR9 
expression. According to their median expression values, TLR2 was highest expressed 
followed by TLRs 4, 1, 7, 5, 3, 6 and finally 10. The inflammatory medium significantly 
promoted an up-regulation of the expression of TLRs 1, 2, 4, 5, 7, and 10, while it 
diminished TLR6 expression in G-MSC-i. Besides of that it partially changed the 
quantitative order of expression leaving TLR2 as the highest expressed TLR followed 
by TLRs 5, 4, 10, 1, 7 and finally 3. The m-RNA level of most G-MSCs’ TLRs in 
inflammatory and non-inflammatory conditions corresponded with the protein 
expression, showing a statistically significant upregulation for TLRs 1, 3 and 7 as well 
as a downregulation in TLR6.  
Different TLRs expression profiles have been described on human MSCs seized from 
various tissues. TLRs 1, 2, 3, 4, 5, 6 and 9 showed expressions in UCB-MSCs [108, 
230]. BM-MSCs displayed wider expression motifs with added TLRs 8 and 10 
expressions [125, 186, 188]. WJ-MSCs exhibited a comparable pattern with marginal 
or deficient expression of TLR4 [146, 186]. Investigations on MSCs derived from dental 
tissues recorded the expression of TLRs 2, 3 and 4 in dental follicle MSCs [28, 226] 
and dental pulp MSCs [226, 249]. TLRs 1, 2, 3, 4, 5, 6, 8, 9 and 10 were expressed in 
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periodontal ligament MSCs [125]. Resembling the outcome of our investigations 
inflammation tended to upregulate the expression of TLR2 [188, 193], TLR4 [188, 205] 
and TLR7 [193] as well as to downregulate the expression of TLR6 [188] in BM-MSCs. 
On the other hand, oral cavity derived fibroblasts showed TLRs’ m-RNA expression 
profiles dissimilar to G-MSCs, as gingival fibroblasts expressed TLRs 1,2,3,4,5,6,7,8 
and 9 [229] and periodontal fibroblasts expressed TLRs 1,2,4,6 and 7 [199] under 
normal culture conditions. In inflammatory conditions periodontal fibroblasts presented 
an upregulation of TLRs 1, 4 and 7 m-RNA, while gingival fibroblasts displayed no 
change of TLR expression [199].  
The presently defined TLR expression profile, especially under inflammatory 
conditions, may affect the therapeutic potential of G-MSCs in-vivo. An upregulation of 
the LPS recognizing TLRs 2 [75, 251] and 4 [75, 106] could raise the G-MSCs’ capacity 
to identify gram-negative periodontal pathogens, including Aggregatibacter 
actinomycetemcomitans, Prevotella intermedia, Porphyromonas gingivalis and 
Tannerella forsythia. The inflammatory upregulation of TLR5 expression could also 
favor the recognition of bacterial flagellin of periodontal pathogens [106, 198] as 
Treponema denticola [203, 208], Campylobacter rectus [99, 208] and Eubacterium 
species [208, 210]. Upregulation of TLR1 and TLR2 could augment lipoproteins’ 
identification [208], while an upregulated TLR7 and TLR9 will promote the ability to 
sense viral pathogens [113, 246]. This pronounced biological process of TLRs’ 
pathogen recognition in inflamed tissue might have positive as well as negative effects 
regarding the tissue regeneration. Understanding the basis of consequences following 
TLR activation and its contribution to the inflammatory response is the first step to 
comprehend this dual role of TLRs. First of all, NFkB activation triggered by TLR 
signaling pathways allows for transcription of genes of different cytokines and 
chemokines responsible for immunomodulatory effects. This in turn leads to a higher 
recruitment of host defensive cells and an overall increased antimicrobial response of 
the host immune system. While this reaction of the host immunity is important to clear 
infections and pathogens, the TLR activated response may have harmful effects to the 
host tissues due to tissue damage and even septic shocks [140]. Furthermore, TLRs 
show close involvement in the phagocytosis of pathogens. This process occurs 
through MyD88, IRAK4, and p38 genes increasing scavenger receptors [49], besides 
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a TLRs mediated internalization of pathogens and maturation of host phagosomes 
[17].  
TLR activation is also capable of inducing the release of non-specific antimicrobial 
peptides by triggering of direct antipathogenic pathways, while these released 
molecules may trigger more TLR activation [92, 241]. In addition, TLR mediated 
response is considered a phase of development and preparation for the adaptive 
immunity by increasing expressed co-stimulatory molecules on dendritic cells allowing  
a more effective T cell activation, as CD80 and CD86 [227]. TLR triggered 
immunomodulation has also been reported to play an important role in influencing the 
adaptive immunity through releasing specific cytokines and soluble factors by the 
MSCs,   directing the differentiation of T cells into T-helper 1 or T-helper 2 subsets with 
either cytotoxic T cell responses or B cells and antibody production [220]. Some studies 
also reported an apoptotic effect through TLR stimulation. LPS has been presented to 
trigger cellular apoptosis through TLR4 [33]. 
Regarding these mechanisms of TLR- mediated immune response, TLR expression at 
sites of the host–pathogen interface is considered a necessary player for pathogen 
recognition, immune response initiation and adaptive response preparation [195].  
On the other hand, various studies have shown negative effects of an increased TLR 
response in different organs resulting in more aggressive inflammations and damaging 
of the host tissues. For instance, high expressions of TLR1 and TLR2 have been linked 
to dermatological diseases as Leprosy, Psoriasis and Acne vulgaris [140]. Tissue 
destruction in several immune disorders has also been described in a number of 
studies to be induced by TLR-mediated pathogen recognition. Among these, TLR4 
was involved in the development of chronic enterocolitis [111] and atherosclerosis 
[148] , while TLR9 activated pathway induced tissue damage in SLE and rheumatoid 
arthritis [20, 235]. In his study, O’Neill describes the dual role of TLR2 and TLR4 
signaling in the lung promoting both, tissue inflammatory destruction and tissue repair 
simultaneously [167]. Nevertheless, TLRs are not only involved in the initiation of the 
inflammatory responses towards the pathogens, but even control the secondary 
induced anti-inflammatory reactions [163]. In the light of this, TLR-mediated 
immunosuppression could create great dangers to the tissues if activated too early 
before total clearance of pathogens in severe infections as investigated with TLR2, 
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TLR4 and TLR9 in [163]. Due to these wide and discrepant repair and damage 
induction roles of TLRs, even TLR targeting procedures have been investigated using 
agonists and antagonists to test possible therapeutic effectiveness of TLR activation 
or blocking during disease [169]. 
Interestingly, one of the biggest challenges facing scientists in therapeutic applications 
of MSCs up till now remains the unpredictability of the results, as well as the 
unstandardized manipulation techniques of MSCs [109, 139]. Several explanations are 
possible for these findings. For example, the source of the MSCs seems to play a role 
defining the function and results gained following clinical treatment trials using the cells 
[66]. More importantly, MSCs’ potential clinical applications encompass a wide variety 
of conditions, ranging from inflammatory and degenerative disorders to autoimmune 
diseases and allograft rejections [40]. Throughout such an extensive spectrum of 
possible therapeutic approaches biological properties of MSCs can be restrained, 
modified or expanded by diverse factors, depending on the microenvironment or the 
stimuli they face at the sites of application [40, 201]. One of the factors shown recently 
to direct the mode of action and biological performance of the MSCs in response to the 
microenvironment are the TLRs [40, 41], which in turn also differ according to their site 
of origin [186]. Based on these outcomes, it can be evidently suggested, that 
knowledge of the source of clinically applied MSCs and their TLR expression profile in 
fields of cell transplantation could show major improvements directing the cells to the 
biological functions needed and avoiding undesirable or unexpected fallouts. 
Therefore, although it might be difficult to predict the effects of an enhanced pathogen 
recognition response in vivo, or other cellular properties promoted by an increased 
expression of TLRs in G-MSCs-I (G-MSCs surrounded by inflammatory factors), this 
study took us one step closer to a better understanding of G-MSCs’ potential 
application in sites of inflammation. However, this subject might need further 
investigations in the future, due to the contrasting possible functions of TLRs in 
detecting infection, regulating the immune response and even in inducing disease.        
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5 Summary and conclusion  
 
Gingival margin-derived stem/progenitor cells (G-MSCs) show a significant potential of 
periodontal regeneration in vivo. During the process of regeneration, G-MSCs may 
interact with their inflammatory milieu via toll-like-receptors (TLRs). The present study 
aimed to depict the G-MSCs TLRs expression profile.  
Cells were isolated from free gingival margins, then STRO-1-immunomagnetically 
sorted and seeded to obtain single colony forming units (CFUs). G-MSCs were 
characterized for the expression of CD14, CD34, CD45, CD73, CD90, CD105, CD146 
and STRO-1 and for multilineage differentiation potential. Following the incubation of 
the cells in basic or inflammatory medium (IL-1β, IFN-γ, IFN-α, TNF-α) a TLR 
expression profile was created.  
G-MSCs showed all stem/progenitor cells characteristic features. In basic medium G-
MSCs expressed TLRs 1, 2, 3, 4, 5, 6, 7, and 10. The inflammatory medium 
significantly up-regulated TLRs 1, 2, 4, 5, 7 and 10 and diminished TLR 6 (p≤0.05, 
Wilcoxon-Signed-Ranks-Test). The current study portrays for the first time the 
distinctive TLRs expression profile of G-MSCs under uninflamed and inflamed 
conditions. 
To conclude, the current study describes for the first time the distinctive TLRs’ 
expression profile of G-MSCs in inflamed and uninflamed conditions, which could 
impact its therapeutic potential in inflammatory environments in-vivo [42]. In light of the 
present results, inflammation tends to upregulate most TLRs’ expression, promoting 
the ability of G-MSCs to recognize important periodontal PAMP in-vivo. 
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7.3 Abbreviations  
AD-MSCs               adipose-derived mesenchymal stem cells   
 
BM-MSCs               bone marrow-derived mesenchymal stem cells 
 
CEJ                         cemento-enamel junction 
 
CFUs                      colony forming units 
 
DF-MSCs                dental follicle-derived mesenchymal stem cells 
 
DNA                         deoxyribonucleic acid 
 
dNTP                        nucleoside triphosphate containing deoxyribose 
 
DP-MSCs                 dental papilla-derived mesenchymal stem cells 
 
dsRNA                           double stranded RNA 
 
EDTA                             ethylenediamintetraacetic acid 
 
FACS                             fluorescence activated cell sorting 
 
FCS                                fetal calf serum 
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FITC                               fluorescein isothiocyanate 
 
G-MSCs                         gingiva-derived mesenchymal stem cells 
 
G-MSCs-i                       G-MSCs in inflammatory medium 
 
H-MSCs                         human mesenchymal stem cells 
 
IDO                                indoleamine-pyrrole 2, 3-dioxygenase 
 
IFN                                 interferon 
 
IL                                    interleukin 
  
LPS                                lipopolysaccharide  
 
MACS                             magnetic activated cell sorting 
 
MAPK                             mitogen-activated protein kinases 
 
MFI                                 mean fluorescence intensity  
 
m-RNA                            messenger ribonucleic acid 
 
NF-κB                              nuclear factor kappa beta  
 
NLRs                                nod-like receptors 
 
PAMPs                             pathogen associated molecular patterns 
 
PBS                                  phosphate buffered saline  
 
PE                                     phycoerythrin 
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PGE2                                prostaglandin E2 
 
PGK-1                               phosphoglycerate kinase 1 
 
PL-MSCs                           placenta-derived mesenchymal stem cells 
 
PRRs                                 pattern-recognition receptors 
 
RLRs                                  (RIG-I)-like receptors 
 
rt-PCR                                real time polymerase chain reaction 
 
ssRNA                                single stranded ribonucleic acid 
 
TIRs                                    toll/interleukin-1 receptors 
 
TLRs                                   toll-like receptors 
 
TNF                                     tumour necrosis factor 
 
UCB-MSCs                          umbilical cord blood-derived mesenchymal stem cells 
 
WJ-MSCs                             wharton jelly-derived mesenchymal stem cel
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